Display options
Cite
Keinänen O, Mäkilä EM, Lindgren R, et al. Pretargeted PET Imaging of . ACS Omega. 2017;2(1):62-69doi: 10.1021/acsomega.6b00269.
Keinänen, O., Mäkilä, E. M., Lindgren, R., Virtanen, H., Liljenbäck, H., Oikonen, V., Sarparanta, M., Molthoff, C., Windhorst, A. D., Roivainen, A., Salonen, J. J., & Airaksinen, A. J. (2017). Pretargeted PET Imaging of . ACS omega, 2(1), 62-69. https://doi.org/10.1021/acsomega.6b00269
Keinänen, Outi, et al. "Pretargeted PET Imaging of ." ACS omega vol. 2,1 (2017): 62-69. doi: https://doi.org/10.1021/acsomega.6b00269
Keinänen O, Mäkilä EM, Lindgren R, Virtanen H, Liljenbäck H, Oikonen V, Sarparanta M, Molthoff C, Windhorst AD, Roivainen A, Salonen JJ, Airaksinen AJ. Pretargeted PET Imaging of . ACS Omega. 2017 Jan 31;2(1):62-69. doi: 10.1021/acsomega.6b00269. Epub 2017 Jan 06. PMID: 28649670; PMCID: PMC5478181.
Copy Download .nbib Format: NLM
Share it on

ACS Omega. 2017 Jan 31;2(1):62-69. doi: 10.1021/acsomega.6b00269. Epub 2017 Jan 06.

Pretargeted PET Imaging of .

ACS omega

Outi Keinänen, Ermei M Mäkilä, Rici Lindgren, Helena Virtanen, Heidi Liljenbäck, Vesa Oikonen, Mirkka Sarparanta, Carla Molthoff, Albert D Windhorst, Anne Roivainen, Jarno J Salonen, Anu J Airaksinen

Affiliations

  1. Department of Chemistry - Radiochemistry, University of Helsinki, A.I. Virtasen aukio 1, 00560 Helsinki, Finland.
  2. Department of Physics and Astronomy, University of Turku, Vesilinnantie 5, 20014 Turku, Finland.
  3. Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, 20520 Turku, Finland.
  4. Turku Center for Disease Modeling, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland.
  5. Department of Radiology, Memorial Sloan Kettering Cancer Center, 417 E 68th Street, 10065 New York, New York, United States.
  6. Department of Radiology and Nuclear Medicine, VU University Medical Center, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands.

PMID: 28649670 PMCID: PMC5478181 DOI: 10.1021/acsomega.6b00269

Abstract

Pretargeted positron emission tomography (PET) imaging based on bioorthogonal chemical reactions has proven its potential in immunoimaging. It may also have great potential in nanotheranostic applications. Here, we report the first successful pretargeted PET imaging of

References

  1. Mol Pharm. 2015 Oct 5;12 (10 ):3575-87 - PubMed
  2. Cancer Chemother Pharmacol. 2013 Aug;72(2):417-27 - PubMed
  3. J Control Release. 2012 Jul 20;161(2):152-63 - PubMed
  4. Angew Chem Int Ed Engl. 2010 Apr 26;49(19):3375-8 - PubMed
  5. Bioconjug Chem. 2013 Jul 17;24(7):1210-7 - PubMed
  6. ACS Nano. 2016 Jan 26;10 (1):1417-24 - PubMed
  7. J Nucl Med. 2013 Aug;54(8):1389-96 - PubMed
  8. J Biomed Mater Res A. 2012 Dec;100(12):3416-21 - PubMed
  9. ACS Nano. 2010 Jun 22;4(6):3023-32 - PubMed
  10. ACS Med Chem Lett. 2015 Dec 10;7(1):62-6 - PubMed
  11. Angew Chem Int Ed Engl. 2009;48(38):6974-98 - PubMed
  12. J Nucl Med. 2015 Sep;56(9):1422-8 - PubMed
  13. J Nucl Med. 2016 Mar;57(3):453-9 - PubMed
  14. Am J Nucl Med Mol Imaging. 2014 Mar 20;4(2):96-113 - PubMed
  15. Bioconjug Chem. 2015 Feb 18;26(2):352-60 - PubMed
  16. Bioconjug Chem. 2016 Feb 17;27(2):298-301 - PubMed
  17. Acc Chem Res. 2011 Sep 20;44(9):666-76 - PubMed
  18. J Pharm Sci. 2008 Feb;97(2):632-53 - PubMed
  19. Bioconjug Chem. 2016 Jul 20;27(7):1707-12 - PubMed
  20. J Control Release. 2010 Feb 15;141(3):265-76 - PubMed
  21. Mol Pharm. 2010 Dec 6;7(6):1899-912 - PubMed
  22. Angew Chem Int Ed Engl. 2013 Sep 27;52(40):10549-52 - PubMed
  23. Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4762-7 - PubMed
  24. J Am Chem Soc. 2015 Sep 9;137(35):11461-75 - PubMed

Publication Types